THBD and COVID-19: The biomarkers for endothelial dysfunction, including VWF, factor VIII, and soluble thrombomodulin levels, were significantly elevated in convalescent COVID-19 patients compared with those for the controls, suggesting that endothelial dysfunction may contribute to long COVID-19 pathogenesis.